EIT Health
Transformative Healthcare Instrument
Last verified:
Details
| Funder | EIT Health |
| Budget | €300k–€500k (max 50% of total project costs) |
| Deadline | 16 September 2026 |
| Consortium | No |
| Application | Single stage; application platform opens 15 July 2026 |
Eligibility & scope
Open to European SMEs (≥4 FTE employees) with ≥€2M total equity investment closed in the prior 36 months. EIT Health funds up to 50% of total project costs; applicant must secure 50% co-funding. Scope: biotech (IML≥5), medtech (IML≥6), digital health/AI (IML≥7), biomarkers/diagnostics (IML≥7). Addresses unmet clinical needs across Europe.
More from EIT Health
Innovation Uptake Call
Deadline: 16 Sept 2026Up to €650k per project; total call budget up to €5.2MBiotech Innovation Path Call
Deadline: 16 Sept 2026Up to €240,000 per projectEntrepreneurship & Innovation Micro-Credentials Call
Deadline: 16 Sept 2026Up to €150k in 2027 + up to €60k in 2028Healthcare Regulations: Ensuring Regulatory Compliance by Design
€300 excl. VAT (course fee)Health Data Privacy: Aligning Innovation and Regulation through PETs (Privacy-Enhancing Technologies)
Browse Related
Could Transformative Healthcare Instrument be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →